Literature DB >> 12354902

Stability of human immunodeficiency virus type 1 RNA in cerebrospinal fluid determined with the AMPLICOR HIV-1 MONITOR test, version 1.5 (ultrasensitive).

Elyse J Singer1, H Aaron Aronow, Shing-Yi Lee, Charles H Hinkin, Tadd Lazarus.   

Abstract

We evaluated the effects of time, temperature, freezing, and thawing on the cerebrospinal fluid viral load by using the Roche AMPLICOR HIV-1 MONITOR test, version 1.5 (ultrasensitive). While a statistically significant decrease from the baseline was observed at 24 h, but not at 6 or 12 h, and with one freeze-thaw cycle, all changes were within the range of intra-assay variability.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12354902      PMCID： PMC130842          DOI： 10.1128/JCM.40.10.3863-3864.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

Review 1.  Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics.

Authors:  J Lew; P Reichelderfer; M Fowler; J Bremer; R Carrol; S Cassol; D Chernoff; R Coombs; M Cronin; R Dickover; S Fiscus; S Herman; B Jackson; J Kornegay; A Kovacs; K McIntosh; W Meyer; N Michael; L Mofenson; J Moye; T Quinn; M Robb; M Vahey; B Weiser; T Yeghiazarian
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

2.  The level of human immunodeficiency virus (HIV) type 1 RNA in cerebrospinal fluid as a marker of HIV encephalitis.

Authors:  P Bossi; N Dupin; A Coutellier; F Bricaire; C Lubetzki; C Katlama; V Calvez
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

3.  Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma.

Authors:  R Sun; J Ku; H Jayakar; J C Kuo; D Brambilla; S Herman; M Rosenstraus; J Spadoro
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

4.  Optimization of specimen-handling procedures for accurate quantitation of levels of human immunodeficiency virus RNA in plasma by reverse transcriptase PCR.

Authors:  R E Dickover; S A Herman; K Saddiq; D Wafer; M Dillon; Y J Bryson
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

5.  Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisons.

Authors:  D Brambilla; S Leung; J Lew; J Todd; S Herman; M Cronin; D E Shapiro; J Bremer; C Hanson; G V Hillyer; G D McSherry; R S Sperling; R W Coombs; P S Reichelderfer
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

6.  Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.

Authors:  R J Ellis; K Hsia; S A Spector; J A Nelson; R K Heaton; M R Wallace; I Abramson; J H Atkinson; I Grant; J A McCutchan
Journal:  Ann Neurol       Date:  1997-11       Impact factor: 10.422

7.  Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.

Authors:  J C McArthur; D R McClernon; M F Cronin; T E Nance-Sproson; A J Saah; M St Clair; E R Lanier
Journal:  Ann Neurol       Date:  1997-11       Impact factor: 10.422

8.  Cerebrospinal fluid viral load is related to cortical atrophy and not to intracerebral calcifications in children with symptomatic HIV disease.

Authors:  P Brouwers; L Civitello; C DeCarli; P Wolters; S Sei
Journal:  J Neurovirol       Date:  2000-10       Impact factor: 2.643

9.  [Clinical importance of the quantification of HIV-1 RNA in cerebrospinal fluid for the diagnosis of HIV encephalitis].

Authors:  P Bossi; S Dupré; N Dupin; A Coutellier; F Bricaire; C Lubetzki; C Katlama; V Calvez
Journal:  Pathol Biol (Paris)       Date:  1998-06

10.  Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease.

Authors:  E J Singer; K Syndulko; B Fahy-Chandon; P Schmid; A Conrad; W W Tourtellotte
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-03
View more
  1 in total

1.  Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment.

Authors:  Karl Goodkin; Benedetto Vitiello; William D Lyman; Deshratn Asthana; J Hampton Atkinson; Peter N R Heseltine; Rebeca Molina; Wenli Zheng; Imad Khamis; Frances L Wilkie; Paul Shapshak
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.